Cargando…
Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
Interstitial lung disease (ILD) is a major cause of morbidity and mortality in patients with systemic sclerosis (SSc). Although a large proportion of SSc patients have only limited interstitial involvement with an indolent course, in a significant minority ILD is progressive, requiring prompt treatm...
Autores principales: | Lota, Harpreet K., Renzoni, Elisabetta A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439977/ https://www.ncbi.nlm.nih.gov/pubmed/22988462 http://dx.doi.org/10.1155/2012/121439 |
Ejemplares similares
-
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
por: Khanna, Dinesh, et al.
Publicado: (2020) -
Telomeres in Interstitial Lung Disease
por: Stock, Carmel J. W., et al.
Publicado: (2021) -
Oxygen in interstitial lung diseases
por: Cordeiro, Ricardo, et al.
Publicado: (2023) -
Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
por: Bonhomme, Olivier, et al.
Publicado: (2019) -
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
por: Erre, Gian Luca, et al.
Publicado: (2020)